<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>https://ecency.com</link><image><url>https://ecency.com/logo512.png</url><title>RSS Feed</title><link>https://ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Wed, 09 Sep 2026 05:27:03 GMT</lastBuildDate><atom:link href="https://ecency.com/created/lacanemab/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[FDA approves lecanemab under its accelerated approval. ]]></title><description><![CDATA[Accelerated approval allows for approval if a drug fills an unmet need for a serious condition based on a surrogate endpoint instead of clinical benefit. The approval can be revoked later if the clinical]]></description><link>https://ecency.com/@zafrada/fda-approves-lecanemab-under-its-accelerated-approval</link><guid isPermaLink="true">https://ecency.com/@zafrada/fda-approves-lecanemab-under-its-accelerated-approval</guid><category><![CDATA[health]]></category><dc:creator><![CDATA[zafrada]]></dc:creator><pubDate>Sat, 07 Jan 2023 01:44:00 GMT</pubDate><enclosure url="https://i.ecency.com/p/26uUsAjKTsXCDw7zixZR182JbFKvgzJ9YwsFpTVcRaGCmsqhA1unTgpra1Kwf2Avsq5j47h3Vd54D24r6A7hi28jqUonDeDdyxv9CjmSwS3mrqyHog6Uc9BVuV4xZdrW8PUczi3MKzeeAAkqVxQ8F7VvRUGuqDq7dNjG2r?format=match&amp;mode=fit" length="0" type="false"/></item></channel></rss>